IRAE
Clinical trials for IRAE explained in plain language.
Never miss a new study
Get alerted when new IRAE trials appear
Sign up with your email to follow new studies for IRAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to fix dangerous blood problems caused by cancer immunotherapy
Disease control Not yet recruitingThis study tests a drug called golidocitinib in 16 people with advanced lung cancer who have severe, hard-to-treat blood problems caused by immunotherapy. The goal is to see if the drug can safely reverse these blood side effects. Participants must not have had cancer growth in t…
Matched conditions: IRAE
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 17, 2026 08:04 UTC
-
Common nausea pill may tame immunotherapy's harsh side effects in liver cancer
Symptom relief Not yet recruitingThis study tests whether ondansetron, a drug typically used for nausea, can lower the risk and severity of side effects from immunotherapy in people with liver cancer. About 134 patients will receive ondansetron alongside their standard cancer treatment. The goal is to see if thi…
Matched conditions: IRAE
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC